Movement disorders can be caused by diminished or slowed voluntary movements (hypokinetic) or increased involuntary movements (hyperkinetic).Parkinson’s disease is the most common of these hypokinetic degenerative disorders, but we also treat progressive supranuclear palsy (PSP), multiple system atrophy (MSA) and corticobasal ganglionic degeneration. Our expertise in hyperkinetic disorders includes Huntington’s disease, Tourette’s syndrome, essential tremor, and dystonia. We diagnose and treat all movement disorders, whether they are caused by primary nervous system dysfunction or by strokes or medications. Our team has expertise in tremor disorders, primary and secondary ataxias, gait disorders, restless legs syndrome, and stiff-person syndrome.

The Pediatric Movement Disorders Program was established to evaluate and treat children with dystonia, chorea, myoclonus, tremor, motor tics, stereotypies, and other paroxysmal disorders of movement. Dr. Nigel Bamford works closely with the Yale Child Study Center , the Yale Comprehensive Movement Disorders Program , and the Department of Neurosurgery to enhance clinical evaluation and available treatments. The clinic is located at Yale New Haven Hospital.

Commonly referred to by one of its brand names, Botox®, Botulinum toxins are widely known as a treatment for wrinkles, but can also help manage dystonia and other movement disorders. We provide diagnostic and therapeutic treatment for patients with hyperactive neurological disorders such as cervical dystonia, hemifacial spasm, blepharospasm, limb dystonia, and spasticity. We also treat other conditions such as chronic migraine and severe axillary hyperhidrosis.